OTLK
Companies
NASDAQ
Outlook Therapeutics Inc.
Health Care
$1.68
-$0.21 (-11.11%)
Price Chart
Overview
About OTLK
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Cap
$158.9M
Volume
663.3K
Avg. Volume
718.4K
P/E Ratio
-0.45136186
Dividend Yield
0.00%
Employees
21.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.07
Moderate Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, OTLK shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$158.9M
Volume663.3K
P/E Ratio-0.45
Dividend Yield0.00%
Important Dates
Next Dividend
March 18, 2019Next Earnings
February 14, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025